Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy
Background: Aberrant galactose-deficient IgA1 molecules (Gd-IgA1) are important causal factors in IgA nephropathy (IgAN); however, the detection of Gd-IgA1 in IgAN is complicated and instable. A monoclonal antibody, KM55, which specifically recognizes Gd-IgA1 has been developed. In the present study...
Saved in:
Main Authors: | Kai Zhang (Author), Qiongqiong Li (Author), Yaru Zhang (Author), Wenya Shang (Author), Li Wei (Author), Hongfen Li (Author), Shan Gao (Author), Tiekun Yan (Author), Junya Jia (Author), Youxia Liu (Author), Shan Lin (Author) |
---|---|
Format: | Book |
Published: |
Karger Publishers,
2019-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Elevated activating Fc gamma receptors levels correlated with susceptibility and severity of IgA nephropathy
by: Hongfen Li, et al.
Published: (2022) -
Prognosis of IgA Nephropathy with Stages 3b-5 CKD
by: Zhanfei Wu, et al.
Published: (2024) -
Leukemia Inhibitory Factor Signaling Enhances Production of Galactose-Deficient IgA1 in IgA Nephropathy
by: Koshi Yamada, et al.
Published: (2020) -
Plasma ST6GAL1 regulates IgG sialylation to control IgA nephropathy progression
by: Youxia Liu, et al.
Published: (2021) -
Clinical significance of IgA nephropathy with hyperuricemia
by: Han Zhou, et al.
Published: (2024)